{"pageContent": "Background: This study sought to compare the effectiveness of aggressive versus nonaggressive treatment in reducing cancer-specific mortality for older men with early-stage prostate cancer across differing comorbid disease burdens at diagnosis.", "metaData": {"source": "Duration of testosterone suppression and the risk of death from prostate cancer in men treated with radiation and 6 months of hormone therapy\nhttps://pubmed.ncbi.nlm.nih.gov/18327816/"}}